Skip to main content
. 2022 Jan 17;13(2):3108–3121. doi: 10.1080/21655979.2022.2025701

Table 1.

The clinicopathologic features of HCC patients (n = 105)

Features Case
Age  
≤ 50 46 (43.8%)
> 50 59 (56.2%)
Gender  
Male 82 (78.1%)
Female 23 (21.9%)
AFP (ng/ml)  
≤ 400 17 (16.2%)
> 400 88 (83.8%)
Tumor diameter (cm)  
≤ 5 41 (39.1%)
> 5 64 (60.9%)
Vascular invasion  
No 22 (20.9%)
Yes 83 (79.1%)
Edmondson  
III–IV 105 (100%)
Sorafenib  
Resistance 29 (27.6%)
Sensitive 76 (72.4%)